Skip to main content

Table 2 Therapy received

From: Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

Surgery (n = 245)

Surgical procedure

Sub-lobar resection

9 4%

Lobectomy

204 83%

Pneumonectomy

32 13%

Chemotherapy

None

112 46%

Adjuvant

126 51%

Neoadjuvant

7 3%

Curative Radiotherapy (n = 132)

 RT dose

≥66Gy

16 12%

60-66Gy

43 33%

SBRT

10 8%

50-59Gy

63 48%

 Chemotherapy

None

98 74%

Concurrent

31 24%

Sequential

3 2%

Non-curative treatment (n = 158)

 Palliative radiotherapy

 

109 69%

 Systemic treatment*

 

12 8%

 Best supportive care

 

44 28%

  1. Values are presented as n (%)
  2. RT radiation, SBRT stereotactic body radiation therapy
  3. *7 patients received both palliative RT and systemic therapy